Search results
Amgen is a global leader in biologic medicines for serious illnesses, such as cancer, inflammation, and cholesterol. Learn about Amgen's science, culture, responsibility, and latest news and stories.
- Careers
Corporate Functions provide company-wide services that...
- Products
Amgen’s medicines treat serious illnesses and typically...
- Contact Us
To report a legal, ethical or compliance concern regarding...
- About
Letter to Our Shareholders. Amgen performed well in 2023,...
- Leadership
The formation of the Amgen Scientific Advisory Boards...
- Investors
Amgen is one of the world's leading biotechnology companies....
- Partners
Partners. Amgen is committed to partnering with innovators...
- Responsibility
Our ESG Framework . Amgen’s ESG framework is built on four...
- Careers
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total.
Learn how Amgen, the world's first biotechnology company, was founded in 1980 and developed groundbreaking drugs such as EPOGEN® and NEUPOGEN®. Explore the milestones and achievements of Amgen's research, innovation and global expansion.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives.
Amgen is a biotechnology company that aims to serve patients by transforming science into therapies. Learn about its mission, values and how it applies the scientific method to its business.
Amgen is a global biotechnology company that develops and delivers human therapeutics for serious illnesses. Amgen Europe has been operating since 1989 and focuses on six therapeutic areas: cardiovascular, oncology, bone health, neuroscience, nephrology and inflammation.
Amgen, Inc. stands out in the biotechnology industry as one of the only businesses to transform itself from a drug development company into a pharmaceutical manufacturer while simultaneously maintaining steady sales.